Roger Olofsson Bagge

46PUBLICATIONS
113CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jul 29, 2026
Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit Metastases.

|Mar 18, 2026
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Axel Nelson, Rebecca Riise, Samuel Alsén

|Mar 12, 2026
Ageing promotes metastasis via activation of the integrated stress response.

Angana A H Patel, Jozefina J Dzanan, Kevin X Ali

|Feb 19, 2026
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.

Hildur Helgadottir, Ana Carneiro, Francesca Portelli

|Jan 10, 2026
Visual Impairment and Cancer Risk: A Nationwide Cohort Study of Adult Swedish Men and Women.

Leda Pistiolis, Henrik Litsne, Roger Olofsson Bagge

|Nov 12, 2025
Impact of an ultra-low dose of superparamagnetic iron oxide on postoperative breast MRI artifacts and skin discoloration in patients with breast cancer.

Nushin Mirzaei, Fredrik Wärnberg, Pontus Zaar

Pageof 8

Frequent Collaborators

10 joint publications

Jonas Nilsson

10 joint publications

Lars Ny

7 joint publications

Dimitrios Katsarelias

4 joint publications

Jan Mattsson